Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Effects of inhaled tiotropium on left ventricular diastolic function in chronic obstructive pulmonary disease patients after pulmonary resection.

Nojiri T, Yamamoto K, Maeda H, Takeuchi Y, Funakoshi Y, Maekura R, Okumura M.

Ann Thorac Cardiovasc Surg. 2012;18(3):206-11.

2.
3.

[Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].

Baloira Villar A, Vilariño Pombo C.

Arch Bronconeumol. 2005 Mar;41(3):130-4. Spanish.

4.

Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.

Kobayashi S, Suzuki S, Niikawa H, Sugawara T, Yanai M.

Respirology. 2009 Jul;14(5):675-9. doi: 10.1111/j.1440-1843.2009.01543.x. Epub 2009 May 19.

PMID:
19476597
5.

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials.

Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin DP, Leimer I, Kesten S.

Int J Chron Obstruct Pulmon Dis. 2011;6:269-75. doi: 10.2147/COPD.S17864. Epub 2011 May 9.

6.

Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.

Nojiri T, Inoue M, Yamamoto K, Maeda H, Takeuchi Y, Nakagiri T, Shintani Y, Minami M, Sawabata N, Okumura M.

Surg Today. 2014 Feb;44(2):285-90. doi: 10.1007/s00595-012-0481-5. Epub 2013 Jan 10.

PMID:
23307265
7.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
8.

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.

Clin Ther. 2012 Aug;34(8):1655-66.e5. doi: 10.1016/j.clinthera.2012.06.005. Epub 2012 Jul 11.

PMID:
22789766
9.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators..

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

10.
11.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105.

12.

Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.

Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S.

Thorax. 2003 Oct;58(10):855-60.

13.

Tiotropium in COPD patients not previously receiving maintenance respiratory medications.

Adams SG, Anzueto A, Briggs DD Jr, Menjoge SS, Kesten S.

Respir Med. 2006 Sep;100(9):1495-503. Epub 2006 May 15.

14.

Exacerbation frequency and course of COPD.

Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP.

Int J Chron Obstruct Pulmon Dis. 2012;7:653-61. doi: 10.2147/COPD.S34186. Epub 2012 Sep 21.

15.

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.

Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, Tashkin D.

Respir Res. 2011 Jan 11;12:6. doi: 10.1186/1465-9921-12-6.

16.

The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.

van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C.

Respir Med. 2009 Jan;103(1):22-9. doi: 10.1016/j.rmed.2008.10.002. Epub 2008 Nov 20.

17.

Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.

Subotic DR, Mandaric DV, Eminovic TM, Gajic MM, Mujovic NM, Atanasijadis ND, Dzeletovic PP, Andric LD, Bulajic BM, Dimitrijevic ID, Sobic DP.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1292-9.

18.

[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].

Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N; ATEM-Studiengruppe..

Pneumologie. 2006 Jun;60(6):341-6. German.

PMID:
16761228
19.

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial.

Decramer M, Celli B, Tashkin DP, Pauwels RA, Burkhart D, Cassino C, Kesten S.

COPD. 2004;1(2):303-12.

PMID:
17136995
20.

[A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease].

Yin KS, Zhang DP, Shi Y, Sun LH, Min R, Xiao YL, Xia XR, Tan Y, Fu WZ.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Jul;33(7):519-23. Chinese.

PMID:
20979799

Supplemental Content

Support Center